



Accumulating in Aging Lens Impairs the Function of a-
Crystallin and Induces Lens Protein Aggregation
Puttur Santhoshkumar
1, Murugesan Raju
1, K. Krishna Sharma
1,2*
1Department of Ophthalmology, University of Missouri–Columbia School of Medicine, Columbia, Missouri, United States of America, 2Department of Biochemistry,
University of Missouri–Columbia School of Medicine, Columbia, Missouri, United States of America
Abstract
Background: The eye lens is composed of fiber cells that are filled with a-, b- and c-crystallins. The primary function of
crystallins is to maintain the clarity of the lens through ordered interactions as well as through the chaperone-like function
of a-crystallin. With aging, the chaperone function of a-crystallin decreases, with the concomitant accumulation of water-
insoluble, light-scattering oligomers and crystallin-derived peptides. The role of crystallin-derived peptides in age-related
lens protein aggregation and insolubilization is not understood.
Methodology/Principal Findings: We found that aA-crystallin-derived peptide,
66SDRDKFVIFLDVKHF
80, which accumulates
in the aging lens, can inhibit the chaperone activity of a-crystallin and cause aggregation and precipitation of lens
crystallins. Age-related change in the concentration of aA-(66-80) peptide was estimated by mass spectrometry. The
interaction of the peptide with native crystallin was studied by multi-angle light scattering and fluorescence methods. High
molar ratios of peptide-to-crystallin were favourable for aggregation and precipitation. Time-lapse recordings showed that,
in the presence of aA-(66-80) peptide, a-crystallin aggregates and functions as a nucleus for protein aggregation, attracting
aggregation of additional a-, b- and c-crystallins. Additionally, the aA-(66-80) peptide shares the principal properties of
amyloid peptides, such as b-sheet structure and fibril formation.
Conclusions/Significance: These results suggest that crystallin-derived peptides such as aA-(66-80), generated in vivo, can
induce age-related lens changes by disrupting the structure and organization of crystallins, leading to their insolubilization.
The accumulation of such peptides in aging lenses may explain a novel mechanism for age-related crystallin aggregation
and cataractogenesis.
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Introduction
The lensis endowed withhighlystable,long-lived proteinsknown
as crystallins. Three lens proteins—a-, b-a n dc-crystallins—
account for nearly 90 percent of the total lens proteins and have
both a structural and a refractive role [1]. The chaperone activity of
the a-crystallin subunits, aA- and aB-crystallin, is believed to be
integraltothemaintenanceof lens transparency[2],[3].Aggregates
of crystallin proteins begin to form during aging, and the lens begins
to accumulate modified proteins. With aging, crystallins slowly lose
their protective mechanisms for maintaining lens clarity and
function [4], [5], leading to deterioration of the optical quality of
the lens and, eventually, to the development of age-onset cataract.
The human lens has both water-soluble (WS) and water-
insoluble (WI) fractions that contain protein aggregates composed
of modified and C-terminally truncated aA- and aB-crystallins,
crystallin fragments, and complexes of a–b–c crystallins [6]–[8].
Compared to young human lenses, aged and cataract human
lenses have significantly increased quantities of crystallin fragments
[9]–[11]. The nuclear region of aged and cataract lenses has the
highest percentage of WI proteins [6], and proteins in the nuclear
region also exhibit the highest degree of age-related modifications
(including truncations) and light-scattering properties [12], [13].
a-Crystallin in aged and cataract lenses also has diminished
chaperone activity [3], [14], [15]. While it has long been known
that in .40-year-old lenses, almost all of the a-crystallin in the
nuclear region is in the WI fraction [16], [17], the reasons for the
preferential insolubilization of a-crystallin in the nuclear region
are not understood. That a-crystallin aggregation is a contributing
factor in the development of lens opacity is further supported by
the recent observation in the lens nuclear region of a significant
decrease in the a-crystallin index (the percentage of scatter from
small particles, representing mostly unbound a-crystallin) and its
association with increasing nuclear opacity grades [18]. There is a
strong correlation between the degree of post-translational modifi-
cation and the degree of crystallin aggregation and insolubilization
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19291but it is yet to be demonstrated whether even the major
modification-deamidation of crystallins [19] can cause the selective
a-crystallin aggregation and insolubilization that occur in aging
lenses [16].
In a previous study, we found that over 25 peptides are present
in aged and cataract human lenses [10]. Among these peptides, we
found that the aA-(66-80) peptide and its truncated forms aA-(66-
75), aA-(67-80), and aA-(67-75) carry a portion of the aA-
crystallin chaperone site [20]. aA-(66-80) and its truncated forms
arise from the b3-strand of native aA-crystallin [21]. The aA-(66-
80) peptide possesses sequence similarity to a region responsible for
fibril formation in b-amyloid [22]. Previous studies have shown
that b-amyloid peptide induces aggregation of a number of
proteins [23]. We therefore hypothesized that peptides arising
from the aA-66-80 region during aging might display properties
similar to those of b-amyloid and, hence, might play a pivotal role
in age-related crystallin aggregation. Studies have shown that
peptides with a propensity to form fibril-like structures aggregate
themselves and also aggregate with other proteins [24]. In the
present study, we show that interactions between a-crystallin–
derived peptide[s] and a-crystallin are sufficient to form high
molecular weight (HMW) aggregates similar to those found in the
nuclear region of human lenses during aging and cataract
formation. Further, we show that intact a-, b-o rc-crystallins
can be recruited to the insoluble complexes formed by the
interaction between the crystallin-derived peptide and a-crystallin,
thus providing the first clue to the molecular mechanisms of age-
related crystallin aggregation and cataract formation.
Results
aA-Crystallin–derived aA-(66-80) peptide
(SDRDKFVIFLDVKHF) distribution in the human lens
We previously showed that a number of peptides and protein
fragments derived from crystallins accumulate in aged and
cataractous human lenses [10]. Among these peptides, aA-(66-
80) peptide and truncated forms of this peptide were conspicuous
because they contained residues that contributed to the chaperone
site we had previously identified in aA-crystallin [20]. To
determine the spatial distribution of the aA-(66-80) peptide in
.70-year-old human lenses, we isolated the peptides from the
cortical and nuclear extracts and subjected them to MALDI
qTOF MS analysis. We found that the aA-(66-80) peptide is
present only in the nuclear region of the .70-year-old lens
(Figure 1A). The temporal concentration of the aA-(66-80) peptide
was estimated using a C
13N
15-labeled aA-(66-80) peptide as an
internal standard in MALDI qTOF MS analysis [25]. The aA-(66-
80) peptide concentration increased with age, and its concentra-
tion was highest in cataract lenses (Figure 1C). Additionally, the
aA-(66-80) peptide was maximally associated with WIS crystallins
(Figure 1B). The WIS-to-WS ratio was 10.0 for aA-(66-80) peptide
in the .70-year-old human lenses. The amount of aA-(66-80)
peptide present in .70-year-old human lenses was 2.3360.6 n
mol per g lens tissue. The WIS fraction of .70-year-old human
lens was estimated to contain 0.5560.03 nmol aA-(66-75),
1.460.1 nmol of aA-(67-80), and 0.3360.02 nmol aA-(67-75)
per g lens tissue, all rising from 66-80 region of aA-crystallin. Since
previous studies have shown that peptides that interact with other
proteins are generally recovered at diminished levels from a
protein-rich media [26], it is likely that the solubilization and
extraction procedure we used did not recover all the peptides
present in .70-year-old lens. Therefore, the actual amount of aA-
(66-80) peptide in aged and cataract lenses could be even higher
than the amount we documented in this study.
aA-(66-80) Peptide and aggregation and precipitation of
a-crystallin
Earlier we reported that in vitro–generated peptides from
oxidized bL-crystallins facilitate the aggregation of denaturing
proteins [27]. Because the bulk of aA-(66-80) peptide was found in
the WIS fraction of aged and cataract lenses, we hypothesized that
this peptide may have a role in insolubilization of a-crystallin in
the nuclear region of lenses. To test our hypothesis in vitro,w e
added synthetic aA-(66-80) peptide to the WS protein fraction of
calf lens extract (CLE, ,1 yr) and of 35-year-old human lens
extract (HLE), prepared in 50 mM phosphate buffer (pH 7.2) and
incubated for 16 h. Lens proteins from this age group of human
lenses were chosen because they represent proteins prior to
complete insolubilization in the nuclear region [16] and are less
modified than the crystallins from lenses older than 50 years,
which have increased concentrations of insoluble a-crystallin in
the nuclear region. Wide-ranging peptide-to-crystallin ratios (1:1.9
to 1:19, w/w) were used to determine the concentration-
dependent effect of peptide on preferential insolubilization of a-
crystallin present in lens extracts. In both CLE and HLE, the
addition of the aA-(66-80) peptide led to a decrease in a-crystallin
in the soluble fraction (Figure 2A and 2B). The decrease was
directly proportional to the amount of peptide added as shown in
Figure 2B with HLE and aA-(66-80) peptide. As we found with
aA-(66-80) added to HLE (Figure 2B), the addition of increasing
amounts of aA-(66-80) peptide to CLE resulted in the precipitation
and removal of increasing quantities of a-crystallin (Figure S1).
More than 50% of the soluble a-crystallin from 200 mg of CLE
precipitated following incubation with 50 mgo faA-(66-80) peptide
(Figure S1). The peptide also caused an increase in the molecular
mass of the lens proteins that remained soluble (Figure 2B). SDS-
PAGE analysis showed that the precipitate formed in CLE after
the addition of aA-(66-80) peptide was composed mainly of a-
crystallin and the aA-(66-80) peptide (Figure 2C, lane 2). SDS-
PAGE analysis of WIS fraction in HLE from a 35-year-old human
lens showed low molecular weight (LMW) peptides (arrow,
Figure 2C) and crystallins and modified proteins (Figure 2C, lane
11), whereas the WS fraction from the same lens showed mainly
proteins ,20 kDa and higher (Figure 2C, lane 10).
The protein elution profiles in Figure 2A also show the effects in
CLE of aA-(66-80) variants found in aged lenses and the effects of
Pro- and Ala-substituted aA-(66-80) peptides, as compared to the
control peptide aA-(1-14) (called peptide A in Figure 2A). The
addition of peptides aA-(66-75), aA-(67-75) and aA-(66-80) to
CLE resulted in maximum precipitation (Figure 2C), whereas the
addition of Pro-substituted aA66-80 peptide (SDRDKFPIFLD-
VKHF) to CLE led to the least amount of precipitation,
comparable to the amount of precipitation with aA-(1-14) peptide
(Figure 2C and 2A inset). Replacing one of the hydrophobic
residues, Val, with less hydrophobic Ala decreased precipitation of
a-crystallin from CLE. Table 1 lists the tested peptides and the
relative effectiveness of the peptides in precipitating crystallins in
vitro during incubation. The peptide-to-crystallin monomer ratio
was 1:8 (mol/mol). Similar to the observations made with CLE,
both aA-(66-80) and aA-(67-75) produced the maximum amount
of crystallin precipitation in HLE from a .35-year-old human
lens, whereas Pro-substituted aA-(66-80) peptide behaved like aA-
(1-14) peptide with minimum protein precipitation. Under the
experimental conditions about 5 mg of crystallins were precipitated
per microgram of aA-(66-80) peptide in 24 h. Decreasing the
hydrophobicity of aA-(66-80) peptide by substitution of a Val by
Ala partially reduced the precipitation of crystallins. However, an
86% decrease in crystallin aggregation and precipitation was
Crystallin Peptides and Age-Related Cataract
PLoS ONE | www.plosone.org 2 April 2011 | Volume 6 | Issue 4 | e19291Figure 1. Distribution of the aA-(66-80) peptide in the lens. (A) MALDI qTOF MS/MS analysis of LMW peptides isolated from the cortex and
nucleus of a .70-year-old human lens as described under methods. The aA-(66-80) peptide characterized in this study is highlighted in the panel
labeled – nucleus. (B) aA-(66-80) peptide concentrations in a .70-year-old lens fractions (WSB, water-soluble bound; WSF, water-soluble free; WIS,
water-insoluble sonicated fractions). The amount of the peptide was estimated using
13C
15N-labelled spiked synthetic peptide standards (AQUA
peptide) during peptide isolation. The inset figure is the standard curve for the isotope cluster area of the AQUA peptide used to determine in vivo
peptide concentration. (C) Concentrations of aA-(66-80) peptide in human lenses of 18-, 44-, 60- and 72-year age groups. Lenses that were 60 years
old were cataract lenses. Values within the bar show the multiple increased concentrations as compared to the 18-year-old lens. The values are mean
6 SD of three analyses. * P,0.001 compared to 18 year, # P,0.01 compared to 44 year, ** P,0.001 compared to 18 and 44 year. P value determined
using ANOVA. These results show an age-dependent increase in the concentration of aA-(66-80) peptide in human lenses and these peptides are
associated with the WIS fraction. The cataract lenses show a higher level of aA-(66-80) peptide than the expected level of the peptide in age-matched
non-cataract lenses.
doi:10.1371/journal.pone.0019291.g001
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(Figure S2 and Table 1).
The data on crystallin aggregation and precipitation by aA-(66-
80) peptide indicate that a-crystallin is the preferential target for
the aA-(66-80) peptide, but that some precipitation of b- and c-
crystallin occurs as well (Figure 2C, lanes 2, 4,5, and 6 with protein
bands .20 kDa). To determine whether b- and c-crystallins
precipitate in the absence of a-crystallin, we incubated HLE after
removing a-crystallin by gel filtration. In the absence of a-
crystallin, b- and c-crystallins from a 70-year-old sample
precipitated to a greater extent than the b- and c-crystallins from
19-year-old sample (Figure S3). The greater precipitation of b- and
c-crystallins, in the absence of a-crystallin, in the aged HLE may
be due to the interaction of aA-(66-80) with b- and c-crystallins
that have undergone age-related modifications.
Hydrophobic interactions are involved in aA-(66-80)-
induced HMW aggregate formation
Hydrophobic interaction is presumed to be one of the major
causes for the a-crystallin aggregation. Since the addition of aA-
(66-80) peptide to a-crystallin results in aggregation of peptide–a-
crystallin complex, we investigated whether peptide-induced
enhancement of hydrophobicity plays a role by using the sensitive
hydrophobic probe Bis-ANS to measure the overall hydrophobic-
ity of proteins. As shown in Figure 3, binding of the aA-(66-80)
peptide to a-crystallin increases the hydrophobicity of the
Figure 2. The aA-(66-80) peptide–induced aggregation and precipitation of crystallins. (A) Size-exclusion column elution profiles of
soluble crystallins from WS CLE (200 mg) following incubation with or without different synthetic peptides (100 mg) for 16 hrs at 37uC. The
chromatography was performed using a TSK G5000PWXL column (7.8 mm630 cm) and the elution was monitored using a 280 nm absorption
detector. The inset in the figure shows the amount of soluble protein recovered after peptide treatment and centrifugation at 3000 rpm for 10 min.
Samples 1-7 in the inset correspond to samples 1-7 analyzed by the size-exclusion column. The results show that the effect of aA-(66-80) peptide is
sequence specific. The addition of aA-(66-80), aA-(66-75) and aA-(67-75) peptides, present in human lens WIS fractions, causes precipitation of
crystallins when incubated with CLE. (B) Effect of the peptide on 35-year-old human lens crystallins. HLE (190 mg) was incubated with various
amounts of synthetic aA-(66-80) peptide for 16 h at 37uC. The samples were centrifuged, and the supernatants were chromatographed on a TSK
G5000PWXL column connected to a multi-angle light scattering instrument (Wyatt Technology). Lines 1a, 2a and 3a show the distribution of
molecular mass across the UV profile of samples 1, 2 and 3, respectively. Mass profiles of samples 4 and 5 could not be analyzed due to instrument
limitations. The results show that the presence of increased amounts of aA-(66-80) peptide in the incubation mixture leads to increased aggregation,
light scattering and precipitation. (C) SDS-PAGE analysis of precipitates of CLE and aA-derived peptides or substituted aA-peptides from panel A and
the WS and WIS fractions from a 35-year-old human lens. The left arrow on lane 1 points to the precipitation of test peptides with crystallins and the
right arrow on lane 11 points to the presence of peptides in human WIS fraction. The results of SDS-PAGE analysis show the precipitate formed when
aA-crystallin-derived peptides are incubated with CLE that contains both the lens crystallins and the peptide tested. The data also confirm the
presence of LMW protein fragments in the WIS fraction from human lenses.
doi:10.1371/journal.pone.0019291.g002
Crystallin Peptides and Age-Related Cataract
PLoS ONE | www.plosone.org 4 April 2011 | Volume 6 | Issue 4 | e19291a-crystallin–peptide complex. We found that the addition of aA-
(66-80) peptide to a-crystallin results in ,30% increase in Bis-ANS
binding. The oligomeric size of the a-crystallin–peptide complex
also increased (Figure 2B), suggesting that peptide-bound a-
crystallin oligomeric size is far greater than the a-crystallin.
However, the intrinsic Trp fluorescence of aA-crystallin did not
show any shift in the emission maximum (data not shown),
suggesting that the environment surrounding Trp residues is not
affected when aA-(66-80) peptide interacts with the protein.
aA-(66-80) peptide interaction with a-crystallin subunits
and HMW aggregate formation
To determine whether the a-crystallin–aA-(66-80) complex
forms a nucleus for protein aggregation, aA-(66-80) peptide was
added to a-crystallin and the aggregate formed was re-suspended
with aB-crystallin that carried the T162C mutation [28], and the
lone thiol group of the mutant was labeled with Alexa fluor 488
(aBT162C-488). The reaction mixture of aA-(66-80) peptide–a-
crystallin aggregates and aBT162C-488 was incubated at 37uC for
6 h. Examination under the fluorescent microscope revealed
that aBT162C-488 was clearly bound to aA-(66-80)-induced a-
crystallin aggregates (Figure 4B), whereas such aggregation was
not observed in samples containing Pro-substituted aA-(66-80)
peptide (Figure 4D). Rather, homogenous distribution of Alexa-
488 labeled aBT162C was observed. Under these experimental
conditions, a-crystallin without peptide or aAT162C-488 showed
a homogenous background without any fluorescence (Figure not
shown). A time-lapse recording of the aggregation assay showed
that the aBT162C-488 binding to aA-(66-80) peptide–a-crystallin
complex begins soon after the incubation is started (Movie S1) and
with time, leads to the formation of larger aggregates. Similarly,
both b- and c-crystallins were found to associate with the a-
crystallin–aA-(66-80) peptide complex (Figures S4A and S4B) but
it took nearly 24 h for the occurrence of significant binding of
labeled b-o rc-crystallins to complexes of a-crystallin–aA-(66-80)
peptide. WI protein from human lenses was re-suspended by
sonication to obtain water-insoluble sonicate supernatant (WISS)
and tested for its ability to interact with aBT162C-488. We found
that the aBT162C-488 was attracted by the WISS only after the










aA-(1-14) CH3-MDVTIQHPWFKRTL Yes 11
aA-(67-75) DRDKFVIFL Yes 142
aA-(66-75) SDRDKFVIFL Yes 44
aA-(66-80) SDRDKFVIFLDVKHF Yes 139
aA-(66-80-Pro) SDRDKFPIFLDVKHF No 14
aA-(66-80-Ala) SDRDKFAIFLDVKHF No 103
aA-(66-80-Scr) FKISDHFKDVFRDVL No 19
Water-soluble extract (2 mg) from 35-year-old human lens was incubated in
50 mM phosphate buffer, pH 7.2 at 37uC for 24 h in the presence or absence of
various peptides (25 mg). The precipitate formed was collected by
centrifugation at 10006g for 10 min and dissolved in buffer containing 7 M
urea and the amount of protein was estimated by Bio-Rad protein assay
method. The values are an average of two independent experiments. Lens
extract alone showed the precipitation of ,12 mg of proteins after 24 h of
incubation. Bold letters in sequence represent substitutions.
doi:10.1371/journal.pone.0019291.t001
Figure 3. Bis-ANS binding to a-crystallin treated with or
without aA-(66-80). a-Crystallin (100 mg) purified from a bovine lens
extract was incubated with and without 10 or 20 mgo faA-(66-80)
peptide in 50 mM phosphate buffer, pH 7.2 for 60 min and 10 mLo f
20 mM bis-ANS prepared in 5% ethanol was added. Fluorescence was
recorded after excitation at 390 nm in a Jasco FP750 spectrofluorom-
eter. The fluorescence for aA-(66-80) was subtracted from the spectra
for the complexes. These data show that the interaction of this peptide
with a-crystallin leads to an overall increase in the hydrophobicity of the
complex.
doi:10.1371/journal.pone.0019291.g003
Figure 4. aA-(66-80) Peptide–induced HMW aggregate forma-
tion. Aggregates formed after incubation mixtures of 25 mg aA-(66-80)
peptide with 200 mg a-crystallin, as described under methods, were re-
suspended with Alexa-488 labelled aB-crystallin (aBT162C-488) in
50 mM phosphate buffer, pH 7.2, and the mixture was incubated at
37uC. The protein sample was removed after 5 min and 6 hrs and
placed on a pre-cleaned glass slide and observed under the Leica
fluorescence microscope using blue filter. The image was captured at
206 magnification. (A) Sample after 5 min; (B) sample after 6 h. As a
control, a mixture of aA-(66-80-Pro) peptide–treated a-crystallin was
incubated overnight and an aliquot was mixed with aBT162C-488 and
observed under fluorescence microscope at 5 min (C) and 6 h D). The
results show that a-crystallin aggregates formed after incubation with
aA-(66-80) peptide bind aB-crystallin. The findings suggest that
peptide- a-crystallin acts as a nucleus for binding of aB-crystallin.
doi:10.1371/journal.pone.0019291.g004
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488 did not interact in the presence of aA-(66-80-Pro) peptide to
emit dense fluorescence from the aggregates (Figure S5C).
Protein concentration affects aA-(66-80) peptide-induced
aggregation of crystallins
The crystallin concentration in human lens is estimated to be
,400 mg/ml [29] and of this amount, ,160 mg/ml is a-
crystallin. Therefore, to determine the effect of a high in vivo
concentration of lens crystallins on peptide-induced aggregation of
lens proteins, aA-(66-80) peptide was incubated at 37uC with 100
to 4000-fold (w/w) excess WS crystallins from 35-year-old human
lenses. The amount of protein precipitated was measured after
24 h of incubation. With a mixture of 5 mgo faA-(66-80) peptide
and 1 mg of lens proteins, in an 18:1 molar ratio of a-crystallin-to-
aA-(66-80) peptide, ,17 mg of protein precipitated from the
reaction mixture (,20 kDa monomer weight for a-crystallin used
in calculation). The amount of precipitate increased to ,40 mg
when the peptide concentration in the incubation mixture was 2-
fold higher (Figure 5A graph with 10 mg peptide) and the crystallin
concentration was 5-fold greater. We found that the amount of
precipitate formed gradually increased with increasing peptide or
crystallin concentrations in the reaction mixture (Figure 5A).
Examination of the precipitates under electron microscopy showed
that interaction of aA-(66-80) peptide with a-crystallin or lens
proteins produced amorphous aggregates (Figure S6 F and H).
Cumulative effects of different a-crystallin peptides
together in the lens
Most of the aggregation-inducing peptides in the lens are found
in the nuclear region of aged and cataract lenses (Figure 1). We
determined the cumulative effects of aA-(66-80), aA-(66-75), aA-
(67-75), aB-(1-18), and bA3/A1-(102-117) peptides, which are all
present in aged and cataract human lenses. A peptide mixture,
5.0 mg, of equal amounts of the above-mentioned peptides was
incubated for 24 h (37uC) with various amounts of soluble protein
isolated from 65-year-old human lenses. After 24 h of incubation
of the reaction mixture, we discovered that a 1:200 ratio of peptide
mixture to crystallins yielded an amount of precipitation
comparable to that observed with 5 mgo faA-(66-80) peptide
and 2 mg of crystallin (Figure 5A and 5B). Figure 5B also shows
that the peptide-induced aggregation and precipitation of lens
crystallin increased dramatically with peptide-to-crystallin ratios of
greater than 1:100 (w/w).
Effect of aA-(66-80) peptide on the chaperone activity of
a-crystallin
After demonstrating in HLE the ability of the aA-(66-80)
peptide to precipitate a-crystallin from the WS fraction, we
investigated whether aA-(66-80) peptide interaction affects the
chaperone activity of a-crystallin and aB-crystallin using ADH
aggregation assay. (Because it is known that both aA- and aB-
subunits display comparable chaperone activity as homo-oligo-
mers and hetero-oligomers, only aB-crystallin was tested in this
study.) As shown in Figure 6, aA-(66-80) incubation with aB-
crystallin resulted in a loss of aB-crystallin chaperone activity.
Furthermore, we observed that the presence of aA-(66-80) peptide
in the absence of chaperone proteins enhanced the aggregation of
denaturing ADH (Figure 6). Saturating concentrations of aA-(66-
80) peptide not only nullified the chaperone activity of aB-
crystallin but also enhanced the aggregation of proteins in the
assay. As with aB-crystallin, purified bovine lens a-crystallin also
exhibited loss of chaperone activity when aA-(66-80) peptide was
used in chaperone assays (Figure S7). The loss of a-crystallin
chaperone activity was proportional to the amount of the peptide
in the reaction mixture. When the reaction mixtures were
observed under EM, only amorphous protein aggregates were
seen with ADH, ADH + aA-(66-80), ADH + a-crystallin + aA-(66-
80) (Figure S6 A-C) and ADH + aB-crystallin + aA-(66-80) peptide
(Figure not shown).
Figure 5. Effect of protein concentration on peptide-induced
aggregation of human lens proteins. (A) Lens crystallin fraction
(0.5–9 mg) was incubated with 2.5–10 mgo faA-(66-80) peptide in 1 ml
buffer at 37uC. The amount of protein precipitated after 24 h was
estimated using Bio-Rad protein assay reagent (n=3). The amount of
precipitate formed increased when the reaction mixture contained
increased amounts of peptide or lens extract. (B) Effect of a mixture of
peptides on lens proteins. Different concentrations of dialyzed human
lens extract were mixed with a mixture of peptides consisting of aA-(66-
80), aA-(66-75), aA-(67-75), aB-(1-18) and bA3/A1-(102-117), 1.0 mg
each, to obtain 5- to 200-fold excess (by weight) of crystallins. The
mixtures were incubated at 37uC for 24 h in 1 ml of 50 mM phosphate
buffer, pH 7.2. The precipitate formed was collected by centrifugation
and estimated as above. The results show that the presence of several
peptides in low concentration is sufficient to induce lens crystallin
precipitation when the crystallin concentration is high. Therefore, an in
vivo lens protein concentration of 400 mg/ml is likely to aggregate and
precipitate even when the peptide concentration is 100’s of times lower
than that of crystallins.
doi:10.1371/journal.pone.0019291.g005
Crystallin Peptides and Age-Related Cataract
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b-amyloid fibril-like structures
Because aA-(66-80) peptide has a b-amyloid signature sequence
[22], we investigated whether this peptide has properties similar to
those of b-amyloid. Indeed, the aA-(66-80) peptide exhibits the
characteristic b-sheet structure (Figure 7A) when analyzed with a
far-UV (ultraviolet) CD spectropolarimeter. Spectral ellipticity was
lost when one of the Val was replaced by Pro to create the peptide
SDRDKFPIFLDVKHF, suggesting that the presence of a b-sheet
breaker Pro disrupts the structure of the peptide. We also found
that thioflavin and Congo Red dyes interact with aA-(66-80)
peptide and show a time-dependent increase in fluorescence (data
not shown). The binding of these two dyes to proteins indicates the
presence of both pre-amyloid-like and amyloid-like structures.
Indeed, amyloid fibril-like structures were found when we
examined by TEM aA-(66-80) incubated for 24 h at 37uCi n
phosphate buffer (pH 7.2), (Figure 7C). At 0 time, the aA-(66-80)
sample had no fibril-like structures (Figure 7B). As expected, the
Pro-substituted aA-(66-80) peptide completely lost its ability to
form fibrils (Figure 7D). The control peptide aA-(1-14) did not
show any fibril-like structures during a 24-h incubation period
(Figure 7E). Incubation of aA-(66-80) peptide with a-crystallin
resulted in complete suppression of fibril formation by the pep-
tide and only aggregates of peptide and a-crystallin was seen
(Figure S6F).
Discussion
Human lenses $50 years old apparently have a negligible
amount of WS a-crystallin in the nuclear region [16], [17]. The
reasons for the partitioning of WS a-crystallin into the WI fraction
over time are not known, but this event is believed to contribute to
the formation of age-related aggregates that accumulate in the
center of the lens. Aged and age-related cataract human lenses
with nuclear opacity show an increased amount of crystallin
fragments as well as aggregated proteins as compared to the young
lenses [9]. Our studies of the peptide distribution in aged and
cataract human lenses show that the WIS fraction has significantly
more peptides than the WS fraction [5], [10]. The hyperbaric
oxygen (HBO)-induced cataract model, designed to mimic the
aging human lens, shows that lens opacity begins developing in the
nuclear region [30]. The nuclear region of HBO-treated guinea
pig lens contains higher levels of crystallin fragments than the
outer cortical region (unpublished data). Previously we reported
that peptides from aged and cataract human lenses have ,4-fold
greater light scattering activity [10]. Based on the current findings
we believe that a nexus exists between crystallin breakdown,
crystallin-derived peptide accumulation, crystallin aggregation and
the development of age-related nuclear cataract. To investigate
further the role of crystallin-derived peptides in lens protein
aggregation and insolubilization of a-crystallin in the nuclear
region of aging lenses, we first determined the distribution of
several aA-crystallin–derived peptides in human lens fractions.
Mass spectrometric analysis and identification of peptides isolated
Figure 6. The aA-(66-80) peptide functions as an anti-
chaperone. The effect of aA-(66-80) peptide on the chaperone activity
of aB-crystallin against denaturing ADH (150 mg) was examined using
the assay procedure described earlier [10]. (1) ADH; (2) ADH+aA-(66-80)
(25 mg); (3) ADH+aB (30 mg)+aA-(66-80) (25 mg); (4) ADH+aA-(66-80)
(50 mg); (5) ADH+aB (30 mg)+aA-(66-80) (50 mg); and (6) ADH+aB
(30 mg). The relative scattering by the samples at the 40-min time
point is shown in the inset graph. As expected, ADH aggregation is
suppressed in the presence of aA-crystallin. But ADH aggregation is
increased in presence of aA-(66-80) peptide, suggesting that the
peptide facilitates the aggregation of denaturing ADH. Additionally, the
chaperone activity of aB-crystallin is diminished in reactions containing
aA-(66-80) peptide, suggesting that the peptide interferes in the
chaperone activity of aB-crystallin that exhibits anti-chaperone activity.
doi:10.1371/journal.pone.0019291.g006
Figure 7. Amyloid-like characteristics of the aA-(66-80) peptide. (A) Far-UV CD spectra of 0.1 mg/ml aA-(66-80) peptide and the Pro-
substituted peptide in phosphate buffer, pH 7.2, obtained as described under methods. Proline substitution abolishes the b-sheet structure of the
peptide. (B, C, D) TEM micrographs of peptides incubated in 50 mM phosphate buffer (pH 7.2) at 37uC. (B) aA-(66-80) at 0 min; (C) aA-(66-80) after
24 h; and (D) TEM of the Pro-substituted aA-(66-80) peptide after 24 h incubation. (E) TEM of the aA-(1-14) peptide after 24 h incubation. TEM studies
show that aA-(66-80) peptide forms fibrils (D), whereas following Pro-substitution, the same peptide is unable to form fibrils (E), suggesting that a
propensity to form b-sheet structure is necessary for fibril formation. The aA-(1-14) peptide did not form fibrils (E) and did not show b-sheet structure
(data not shown).
doi:10.1371/journal.pone.0019291.g007
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crystallin are present only in the nuclear region (Figure 1A). Mass
spectrometric imaging of human lens cross sections has also shown
that a number of crystallin-derived peptides are present in the
nuclear region of human lens and that a concentration gradient for
the peptides exists in which the innermost region of the lens has
the highest concentration of the peptides whereas the outermost
region has the lowest amount of peptides [5], [11]. Of the peptides
identified from the nuclear region, aA-(66-80) is the most
prominent member and it consists of residues 70-80 in aA-
crystallin that contribute to the chaperone site [20]. We found that
the amount of aA-(66-80) peptide present in .70-year-old human
lenses is 2.3360.6 nmol/g lens (or 7.2861.8 nmol/g lens protein
if we assume that 32% of lens weight is protein [1]). This value is
significantly higher than the highest amount of lens b-amyloid (Ab,
1.37 nmol/g lens protein) found in lenses from Alzheimer’s disease
(AD) patients [31] or the amount of Ab in brain tissue of AD
patients (0.0160.001 nmol/g soluble protein and 0.2260.01 nmol/
g insoluble protein) [32]. In addition to aA-(66-80) peptide, we also
estimated that the WIS fraction of .70-year-old human lens also
contains 0.5560.03 nmol aA-(66-75), 1.460.1 nmol of aA-(67-80),
0.3360.02 nmol aA-(67-75) per g lens tissue, all rising from 66-80
region of aA-crystallin and capable of precipitating a-crystallin.
At this time it is not known how aA-(66-80) peptide is generated
in aging lenses since we cannot attribute the action of a specific
lens protease to the generation of the peptide. The aA-(66-75), aA-
(66-80) and aA-(67-75) peptides are likely to be generated from
aA-(66-80) peptide by the action of aminopeptidases and
carboxypeptidases in the lens [33], [34]. It is unclear why only a
few peptides from a given crystallin are present in the cortical and
nuclear regions of the lens (Figure 1A) while the rest of the peptides
generated during proteolysis of crystallins are completely degraded
into amino acids. We hypothesize that binding of the peptides to
other crystallins may be protecting them from the action of
peptidases. Further studies are underway to confirm this.
The data on crystallin aggregation and precipitation (Figures 2,
S1 and S2) by aA-(66-80) peptide indicate that a-crystallin is the
preferential target for the aA-(66-80) peptide, but that some
precipitation of b- and c-crystallin occurs as well. In the absence of
a-crystallin, b- and c-crystallins from 74-year-old HLE precipi-
tated to a greater extent than b- and c-crystallins from 19-year-old
HLE (Figure S3). The heightened precipitation of b-and c-
crystallins, in the absence of a-crystallin, in the aged HLE may be
due to the interaction of aA-(66-80) with b- and c-crystallins that
have undergone age-related modifications. Studies are needed to
confirm this possibility and to identify the aA-(66-80) interaction
sites in precipitating crystallins. The data indicate that the peptides
aA-(66-80), aA-(66-75) and aA-(67-80), along with aB-(1-18) [10]
and bA3/A1-(59-74) [35], might be involved in the aggregation
and insolubilization of a-crystallin in the nuclear region of human
lenses during aging. a-Crystallin aggregation and complete
insolubilization in the nuclear region of aged lens was first
reported in 1976 [16], but the mechanisms underlying aggregation
and precipitation remain unknown. It is yet to be determined
which other peptides among .25 peptides present in aged human
lenses [10] also interact with crystallins, induce aggregation and
precipitation.
Based on our earlier study [36] and the data presented here, it
appears that binding of the aA-(66-80) peptide to a-crystallin
increases the hydrophobicity of the a-crystallin–peptide complex
(Figure 3), with a concomitant gain of function, leading to the
additional binding of a-, b- and c-crystallins to form HMW
complexes (Figures 2B, 4 and S5) that precipitate rapidly. We
believe that the peptide binds to a-crystallin subunits, at multiple
sites, as in the case of bA3/A1-(102-117) peptide binding to aB-
crystallin [35], to bring about conformational change sufficient to
increase the overall hydrophobicity of the complex above that of
native protein. An increase in the net attractive forces between
hydrophobic complexes formed by aA-(66-80) peptide and a
decrease in the stability of these complexes are likely involved in
aggregation and precipitation of crystallins in complex with
peptides found in aging lenses.
The inability of Pro-substituted aA-(66-80) peptide to precip-
itate a-crystallin from HLE and the decreased precipitation of a-
crystallin with Ala-substituted aA-(66-80) peptide (Figure 2A and
Table 1) suggest that the propensity to form b-sheet structure and
relative hydrophobicity are important attributes of a peptide
involved in a-crystallin insolubilization. In addition, the aggrega-
tion-inducing activity of aA-(66-80) peptide appears to be
sequence specific because aA-(66-80-scr) (a peptide having the
scrambled aA-(66-80) peptide sequence) was unable to precipitate
a-crystallin from the lens extract (Figure S2 and Table 1). The
sequence specificity is further highlighted by the inability of
hydrophobic b-sheet-forming aA-(70-88) peptide to precipitate a-
crystallin from lens extracts. The precipitation of a-crystallin
present in CLE and HLE by aA-(67-75) and aA-(66-75) (Figure 2A
and Table 1) shows that more than one peptide generated from
aA-(66-80) region of aging human lenses has the ability to cause a-
crystallin aggregation and precipitation and that the minimum
sequence required for this action is aA-(67-75).
Depletion of a-crystallin from HLE or CLE in response to the
addition of aA-(66-80) peptide was proportional to the amount of
peptide added to HLE or CLE when a fixed concentration of lens
extract was used (Figures 2B and S2). However, when an
increasing amount of CLE was used, increased precipitation of
the a-crystallin–peptide complex occurred (Figure 5A), and when
the peptide-to-HLE ratio was over 100, there was an exponential
increase in the precipitation of crystallins from HLE (Figure 5B),
suggesting that a low concentration of aA-(66-80) peptide or a
mixture of peptides having similar properties is sufficient to bring
about significant precipitation of a-crystallin from HLE. The
lowest aA-(66-80) peptide concentration (2.5 mg/ml) that caused
lens protein precipitation during incubation (Figure 5A) was less
than the in vivo aA-(66-80) peptide concentration confined to the
nuclear region of a 72-year-old human lens (Figure 1C). Since
1 mgo faA-(66-80) peptide alone has the potential to precipitate
5.6 mg of lens proteins in 24 h when the lens protein concentration
is 2 mg/ml (Table 1), and since crystallin precipitation increases
with increased HLE concentrations, we can predict that the
combined action of several peptides in vivo would result in the
precipitation of several hundred micrograms of crystallins. The
aA-(66-80) peptide was 5-fold more effective in precipitating
crystallins compared to the cytosolic protein precipitation activity
of b-amyloid [23]. b-Amyloid as well as b-sheet-forming proteins
are known to cause aggregation of cellular proteins [24], [37] and
this process is implicated in protein aggregation diseases. The
possibility that crystallin aggregation and precipitation occurs from
the combined action of crystallins and peptides is underscored by
the fact that the aging lens has several peptides capable of
precipitating a-crystallin [10] and the peptides have a cumulative
effect on crystallin aggregation and precipitation (Figure 5B) are
primarily confined to the lens nuclear region (Figure 1), whose
volume is a fraction of estimated lens volume of ,225 ml. Further,
the peptides accumulate in vivo for several years and to decades,
thereby providing ample time to interact and cause precipitation.
We found that aA-(66-80) peptide starts to accumulate as early as
18 years of age. By 70 years of age, we found that the amount of
aA-(66-80) peptide is increased at least 7-fold as compared to the
Crystallin Peptides and Age-Related Cataract
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with a-crystallin appears to result in the attraction of additional
crystallin molecules (Figure 4B) in a crowded environment to form
larger aggregates that precipitate with time. This view is supported
by data from Alexa-labeled aB-, b- and c-crystallins and time-
lapse experiments, which demonstrated that incubation with the
aA-(66-80) peptide induces the formation of HMW crystallin
aggregates (Figures 4B, S4 and S5).
It is known that the molecular crowding effect on protein
aggregation is non-linear and that as the protein concentration
increases, the aggregation increases exponentially [38]. Based on
our observations of increasing lens crystallin precipitation with
increasing amounts of crystallin extract and a mixture of aA-(66-
80), aA-(66-75), aA-(67-75), aB-(1-18) and bA3/A1-(102-117)
(Figure 5B), we believe that the presence of several different
peptides at low concentrations in vivo is sufficient to precipitate a
significant portion of lens crystallins and cause light scatter, as seen
in aged cataract lenses. We and others estimate that the
degradation of crystallins in aged lenses is as much as 10 to 20
percent of the total lens proteins [9], [10], [39]. Of the degraded
crystallins, those that are ,4 kDa will be present in a
concentration of 0.8 to 1.2 mg per lens [10]. We estimate that
crystallin aggregation activity in merely 10 percent of the ,1m g
peptides in a lens [10] would be equivalent to the interaction of
100 mg of peptides with ,40 mg a-crystallin in a confined lens
volume of ,225 ml. A conservative estimate of precipitation in this
scenario is .500 mg of proteins. We know from numerous in vitro
experiments that precipitation of ,25 mg protein is sufficient to
scatter light. Additionally, from the data in Figure S3, we reason
that age-related modifications increase the susceptibility of b- and
c-crystallins to precipitation. Taken together, the results of our
study suggest that age-related accumulation of crystallin-derived
peptides and their interaction with other crystallins in a volume-
excluding environment may be responsible for the partitioning of
a-crystallins into WIS fraction in lenses over 40 years of age. Such
partitioning of a-crystallins was first reported in 1976 [16] but
what underlies such age-related changes remained unknown till
now.
In previous studies, we demonstrated the existence of anti-
chaperone activity in crystallin fragments prepared in vitro from
oxidized lens proteins and in a bA3/A1-crystallin fragment from
aged lenses [27], [35]. However, our demonstration in the current
study of aA-(66-80) anti-chaperone activity in the WIS fraction of
lens extracts is particularly important because the aA-(66-80)
peptide is found in aged and cataract lenses and is derived from
aA-crystallin, a small heat shock protein [sHSP] chaperone whose
function is critical for maintaining lens transparency [2].
Amyloid-like fibrils have been noted to form when a, b and c-
crystallins are incubated at 60uC in the presence of 1 M guanidine
hydrochloride (GnHCl) or under acidic conditions [40]. Other
investigators also found that aA-(70-88) peptide aggregates into
amyloid fibril-like structures when incubated at pH 2.0 or after
exposure to 1 M GnHCl or after vigorous shaking at 60uC [41].
Our study is the first observation of fibril formation by a peptide
from aA-crystallin under physiological pH conditions in vitro.W e
propose that the 70-80 region in aA-crystallin is responsible for the
formation of amyloid-like fibrils from aA-crystallin.
Proposed mechanism for peptide-induced lens aging
and cataract development
We found that a correlation exists between crystallin aggregate
formation in vivo during lens aging and aA-(66-80) peptide-induced
aggregation of soluble lens crystallins in vitro. Therefore, we suggest
that aA-(66-80) peptides in the lens play an integral role in lens
aging and cataract development. Based on our data, we propose a
mechanism for peptide-induced lens aging (Figure 8). For an as yet
unknown reason, aA-(66-80) peptide is released from aA-
crystallin. The peptide preferentially interacts with a-crystallin.
At low concentrations, aA-(66-80) induces a conformational
change in a-crystallin, increasing the hydrophobicity of a-
crystallin, decreasing its chaperone-like function, and enhancing
the association between a-crystallin subunits, all characteristics of
a-crystallins in aged lenses. At higher concentrations, aA-(66-80)
causes the precipitation of a-crystallins and other proteins, which
manifest as a cataract. It is difficult to estimate the amount of aA-
(66-80) required for cataract formation, as other anti-chaperone
peptides and post-translational modifications can also contribute
to cataract development, as has been shown with HBO-induced
cataract model. It should also be noted that our study of the effects
of aA-(66-80) revealed that b- and c-crystallins from 70-year-old
human lenses, known to have undergone increased oxidation and
modifications, precipitate to a greater extent than the b- and c-
crystallins from 19-year-old lenses when same amount of the
peptide is used (Figure S2).
We did not find any peptide in vivo that can counteract the
effects of the aA-(66-80) peptide. Rather, we found additional
peptides—aA-(66-75), aA-(67-75), aA-(67-80), aB-(1-18), and
bA3/A1-(102-117)—in the lens with properties similar to those
of the aA-(66-80) peptide. While the aA-(66-80) peptide has the
propensity to form fibrils in vitro, it is not apt to form similar
structures in vivo because a-crystallin would most likely sequester
these peptides and the effective concentration of the free peptide
would be kept low (Figure 8). In support of this possibility, we
observed that only HMW aggregates were formed when the aA-
(66-80) peptide was incubated with a-crystallin or HLE (Figure S6
F and H).
Taken together, the results of this study reveal a novel
mechanism for age-related crystallin aggregation and the forma-
tion of cataracts. Known for many years as one of the least
understood protein conformational diseases, cataracts are a major
Figure 8. Schematic of aA-(66-80) peptide–mediated lens aging
and cataract development. In vivo aA-(66-80) peptides interact with
crystallins and affect the structure and organization of crystallins,
leading to age-related changes and cataract development. At low
concentrations, aA-(66-80) specifically interacts with a-crystallin, result-
ing in increased hydrophobicity and polydispersity and decreased
chaperone activity of a-crystallin. At higher concentrations, aA-(66-80)
binds to crystallins, leading to insolubilization of crystallins and cataract
development. Localized accumulation of the aA-(66-80) peptide has the
potential to form light-scattering amyloid-like structures. However, the
latter is less likely because the interaction of the peptide with crystallins
suppresses the formation of fibrils.
doi:10.1371/journal.pone.0019291.g008
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million people worldwide. This study demonstrates a number of
important observations that expand our understanding of cataract
formation: 1) The aA-(66-80) peptide generated in human lenses
interacts with a-crystallin and causes its aggregation and
precipitation, as seen in aging and cataract lenses; 2) the aA-(66-
80) peptide binds to denaturing b- and c-crystallins, facilitating
their aggregation; 3) the interaction of aA-(66-80) peptide with a-
crystallin renders the interaction site as a nucleation site that
attracts a-, b- and c-crystallins to form HMW aggregates, 4) a high
protein concentration (molecular crowding) leads to increased
peptide-induced aggregation and precipitation of lens crystallins,
and 5) the aA-(66-80) peptide suppresses the chaperone activity of
a-crystallins. Our identification of the aA-(66-80) peptide as one of
the causative agents of lens protein aggregation begins a new path




The peptides used in this study were obtained from GenScript
Corporation (Piscataway, NJ), and the University of Missouri
Structural Biology Core Facility. The purity level of the synthetic
peptides exceeded 95%. The peptides (2 mg) were dissolved in
1 ml of sterile water. Peptides that were not readily soluble were
briefly sonicated to solubilize them. The samples were then filtered
through a 0.2 mm filter, and the concentration of the peptide was
estimated using the micro-BCA protein assay kit (Thermo
Scientific). The peptide incubations and assays were carried out
in phosphate buffer (50 mM sodium phosphate buffer containing
150 mM NaCl, pH 7.2), unless otherwise mentioned. The AQUA
peptide, SDRDKFV(IC
13N
15)FLDVKHF, (.96% purity) was
obtained from Sigma-Genosys. Synthetic peptides were used in
binding, aggregation and precipitation studies.
Isolation of low molecular weight (LMW) peptides from
human lenses
Human donor lenses were obtained from the Heartland Lions
Eye Bank (Columbia, MO) and kept at 270uC until use. Cataract
lenses were obtained as a kind gift from the Patney Eye Clinic
(Rajkot, India) and were stored frozen at 270uC until use.
Provisions of the Declaration of Helsinki for research on human
tissue were followed while collecting the lenses. Indian cataract
lenses used in the study were of type 2, as described by Pirie [42].
The lenses were thawed on ice, and the capsules were carefully
removed with a forceps. To isolate the water-soluble-free (WSF)
peptides, the lenses were homogenized in 6.0 ml of homogenizing
buffer (phosphate buffer saline, pH 7.4, containing 2 mM Tris(2-
carboxyethyl) phosphine hydrochloride (Thermo Scientific) and
5 ml of protease inhibitor mixture and then centrifuged at 160006
g for 1 h. The supernatant was then passed through a 10 kDa cut-
off filter (Millipore) to obtain the WSF peptides. The retentate of
the 10 kDa cut-off filter was treated with homogenizing buffer
containing 6 M urea to dissociate peptides bound to proteins and
was then centrifuged, as above, to collect the water-soluble–bound
(WSB) peptides. The WIS fraction was treated with 6 ml of
homogenizing buffer containing 6 M urea and sonicated on ice for
30 sec, followed by centrifugation and 10 kDa filtration to isolate
WIS peptides. To isolate the cortical and nuclear peptides, the
lenses were stirred on ice, using a micro-stir bar, in 3 ml of
homogenizing buffer containing 6 M urea until the cortex had
dissolved (about 3 min). The nuclear fractions of the lens were
then transferred to a fresh tube and homogenized with 6 ml of the
same buffer. Both the cortex and the nuclear fractions were then
processed, as described above, to collect the LMW peptides.
Peptides isolated from human lenses were used in identification/
quantification studies.
Determination of aA-(66-80) peptide concentration in
the aged lens
AQUA peptide (1 nmol) was dissolved in 100 ml of a 10% (v/v)
formic acid solution. Two stock solutions of AQUA peptide
(0.4 pmol/ml and 4 pmol/ml) were prepared in acetonitrile/water/
90% formic acid buffer (30:69:1). Different amounts of AQUA
peptide (0–40 pmol) were spiked into 150 ml of LMW peptide
fractions. The samples were desalted using PepClean C18 columns
(Thermo Scientific). The bound peptides were eluted using 70%
acetonitrile containing 0.1% formic acid. For mass spectrometry
analysis, 5 ml of the sample was added to 5 ml of alpha-cyano-4-
hydroxycinnamic acid, and 0.5 ml of the mixture was applied to
the sample target and analyzed with a 4700 MALDI TOF/TOF
mass spectrometer (Applied Biosystems Inc.). The amount of aA-
(66-80) present in the lens was calculated from the AQUA peptide
standard graph.
Protein aggregation analysis
WI aggregates were separated from the lens extract and peptide
incubations by centrifugation at 3000 rpm for 10 min. The soluble
fraction was injected into a TSK G5000PWXL (Tosoh Bioscience)
gel filtration column connected to a high-performance liquid
chromatography (HPLC) (Shimadzu, Columbia, MD) coupled to
multi-angle light- scattering and dynamic light-scattering detectors
(Wyatt Technology, Santa Barbara, CA). The amount of protein
that remained soluble in the incubation mixture and the molecular
mass were determined using ASTRA software (Wyatt Technolo-
gy). The WIS aggregates from the incubation mixtures were
analyzed by SDS-PAGE.
aA-(66-80) peptide in HMW aggregate formation
aA-(66-80) Peptide (25 mg) was added to 200 mgo fa-crystallin
in phosphate buffer (0.2 ml of 50 mM, pH 7.2) and the mixture
was incubated at 37uC. After overnight incubation, a visible
aggregate was observed in a-crystallin samples with peptides,
whereas no visible precipitate was seen in a-crystallin without
peptides. The aggregate was collected by centrifugation and the
pellet was re-suspended with a cysteine-substituted aB-crystallin
labeled with Alexa fluor 488 (aBT162C-488). The single cysteine
residue of aBT162C was labeled with a thiol reactive Alexa fluor
488 dye, as per the protocol of the manufacturer (Molecular
Probes). The reaction mixture was incubated further at 37uC. The
protein sample was removed at 5 min, 6 h, and 24 h and placed
on the pre-cleaned glass slide and observed under the fluorescence
microscope using blue filter. The image was captured at 206
magnification in a Leica microscope. As a control, a mixture of
aA-(66-80–Pro) peptide–treated a-crystallin+aBT162C labeled
with Alexa fluor 488 was used. The binding of b- and c-crystallins
to peptide-induced a-crystallin aggregates was investigated by the
addition of Alexa fluor 488–labeled b-o rc-crystallins in place of
aBT162C-488.
Peptide-induced aggregation of lens crystallins
Human lenses (65 years old) were homogenized in phosphate
buffer containing 6 M urea. The urea-soluble supernatant was
collected by centrifugation of the homogenate at 150006g for 1 h.
The supernatant was dialyzed (10 kDa) against phosphate buffer
to remove urea and LMW peptides. The dialyzed sample was used
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collect the a-crystallin fraction. Different amounts of total lens
extract or a-crystallin were incubated, with or without peptide(s),
at 37uC in 1 ml phosphate buffer. At the end of incubation the
tubes were centrifuged at 150006 g for 20 min to collect the
insoluble aggregates. The pellet was solubilized in 6 M urea and
the amount of protein was estimated using Bio-Rad protein assay
reagent. The amount of protein precipitates in control tubes was
subtracted from the precipitates in peptide-treated tubes to
estimate the peptide-induced protein precipitation.
Time-lapse recording of aA-(66-80) peptide-induced
HMW aggregate formation
aBT162C-488 was added to a-crystallin–aA-(66-80) peptide
aggregate, as above, and an aliquot was taken in a glass slide with a
well. The sample was photographed in an Olympus IX70 inverted
microscope every minute for 5 h. The images were compressed
into a movie using MetaMorph software (Molecular Devices, Inc.,
Sunnyvale, CA).
Circular dichroism (CD) spectroscopy
The aA-(66-80) peptide (0.1 mg/ml in phosphate buffer) was
examined immediately after preparation. CD spectra were
acquired with a Jasco J-815 CD spectropolarimeter (Jasco Inc.,
Easton, MD) using a 2.0-mm cuvette at 25uC. The spectrum
derived represents an average of six scans.
Transmission electron microscopy (TEM) study
The morphology of amyloid-like fibril formation by the aA-
(66-80) peptide was studied by TEM (Jeol, Ltd., Tokyo, Japan).
Briefly, the aA-(66-80) peptide (1 mg/ml) was suspended in
phosphate buffer and incubated at 37uC for different time
intervals, ranging from 0 h to 24 h. Aliquots (5 ml) were applied
to carbon-coated, Formvar-filmed 400 mesh copper grids at room
temperature and left for 1 min. The excess solution was then
wicked away with filter paper. The peptides on the grid were
stained with 5 ml of 2% (w/v) uranyl acetate solution for 1 min.
This solution was then wicked off, and the grid was air-dried and
then examined using a JEOL 1400 TEM (120 kV). TEM was
operated at 80 kV. The images were obtained using digital
imaging software from Gatan Digital Micrograph, (Gatan, Inc.,
Warrendale, PA).
Supporting Information
Figure S1 Effect of different concentrations of the aA-
(66-80) peptide on the calf lens extract (CLE). CLE,
200 mg, was incubated with different amounts of aA-(66-80) in
50 mM phosphate buffer, pH 7.2 at 37uC for 16 h. The total
incubation volume was 155 ml. After incubation, the samples were
centrifuged and 100 ml of the supernatant was analyzed in a multi-
angle light scattering (MALS) system. Peaks of a, bH, bL and c-
crystallin are marked. The inset graph shows the percentage of
soluble lens proteins recovered after incubation with the peptides.
The results show that the interaction of aA-(66-80) with the CLE
results in selective removal of a-crystallin.
(TIF)
Figure S2 Comparison of crystallin aggregation induc-
ing activity of aA-(66-80) peptide and a peptide having
the scrambled aA-(66-80) sequence, aA-(66-80-scr). The
peptides were incubated with CLE as described in Figure 2 and
the precipitate formed was removed by centrifugation and the
soluble proteins were analyzed adopting the procedure described
in legend for Figure 2. The results show that scrambled peptide of
aA-(66-80) has negligible a-crystallin precipitation activity.
(TIF)
Figure S3 Effect of the aA-(66-80) peptide on 19- and 70-
year-old HLE that lacked a-crystallin. The a-crystallin
fraction was removed from HLE by gel filtration. The b- and c-
crystallin fractions were pooled and incubated with 50 mg of the
aA-(66-80) peptide in phosphate buffer. After 16 h at 37uC, the
reaction mixture was centrifuged, and the soluble fraction was
analyzed by multi-angle light scattering. The amount of protein
that remained soluble at the end of incubation is depicted in the
figure. The results show that, in the absence of a-crystallin, b- and
c-crystallins interact with the aA-(66-80) peptide, and this
interaction leads to the precipitation of the complex. In addition,
crystallins from aged lenses appeared more susceptible to
precipitation by the peptide.
(TIF)
Figure S4 aA-(66-80) Peptide–induced aggregation of
crystallins to form HMW aggregates. Visible aggregates
from the overnight incubation of aA-(66-80) peptide (25 mg) and
a-crystallin (200 mg) in phosphate buffer (50 mM, pH 7.2) at 37uC
were re-suspended in Alexa fluor 488–labeled b- (A) or c-
crystallins (B) and incubated further. The protein sample was
removed at 5 min, 6 h and 24 h and placed on a pre-cleaned glass
slide and observed under the fluorescence microscope using a blue
filter. The image was captured at 206 magnification. In the
absence of aA-(66-80) peptide, fluorescently labeled b- and c-
crystallin show no association with a-crystallin for 24 h (panel a).
Both b- and c-crystallins, albeit slowly when compared to a-
crystallin (Fig. 3), were incorporated into aA-(66-80) peptide–a-
crystallin aggregates (panels b, c, and d). Based on these data we
propose that in vivo interaction of aA-(66-80) peptide may be
responsible, at least in part, for the formation of HMW aggregates
composed of a-, b- and c-crystallins.
(TIF)
Figure S5 The aA-(66-80) peptide recruits proteins to
HMW aggregates. The aA-(66-80) peptide (25 mg) was added to
WISS proteins (200 mg) from human lens in phosphate buffer
(50 mM, pH 7.2). The mixture was incubated at 37uC overnight.
The tubes were centrifuged to remove soluble-free peptides. The
insoluble aggregates were incubated further at 37uC for 6 h with
Alexa fluor 488–labeled aB-crystallin (aBT162C-488). At the end
of incubation, the sample was observed under fluorescence
microscope, as described earlier. A. WISS + aBT162C-488;
B. WISS +aA-(66-80) +aBT162C-488; C. WISS +aA-(66-80-pro) +
aBT162C-488. The results show that in about 6 h, aBT162C-488
binds to WISS treated with aA-(66-80) peptide, whereas such an
interaction does not occur in the absence of aA-(66-80) peptide or
with samples treated with aA-(66-80-Pro) peptide. Based on these
data, we propose that in vivo interaction of aA-(66-80) peptide may
be responsible, at least in part, for the formation of HMW
aggregates.
(TIF)
Figure S6 Suppression of aA-(66-80) peptide fibril
formation by ADH and crystallins. TEM micrographs of
proteins and peptides following aggregation reactions. Protocol for
TEM is described under methods. (A) ADH (250 mg); (B) ADH
(250 mg) + aA-(66-80) peptide (25 mg); (C) ADH (250 mg) + a-crys-
tallin (100 mg) + aA-(66-80) peptide (25 mg); and (D) aA-(66-80)
peptide (1 mg/ml) incubated at 37uC for 24 h. A, B and C
represent samples from Figure S7. Experiment details are included
in the legend for Figure S7. (D) Sample was prepared as described
Crystallin Peptides and Age-Related Cataract
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phosphate buffer (pH 7.2) at 37uC for 24 h and then examined
under TEM. (E) a-Crystallin (1 mg/ml); (F) aA-crystallin
(0.2 mg) + aA-(66-80) peptide (25 mg); (G) HLE (1 mg/ml); and
(H) HLE (1 mg/ml) + aA-(66-80) peptide (25 mg). The results
show that aA-(66-80) peptide does not form fibrils in the presence
of ADH, aA-crystallin or HLE that has structure similar to that of
fibrils formed by the peptide.
(TIF)
Figure S7 Anti-chaperone activity of the aA-(66-80)
peptide against bovine a-crystallin in the ADH aggrega-
tion assay. Aggregation assay was carried out, as described
earlier [10], after incubation of a-crystallin with the peptide for
35 min at 37uC. The results show that the aA-(66-80) peptide is
capable of suppressing the chaperone activity of a-crystallin.
(TIF)
Movie S1 Time-lapse recording of binding of aBT162C-
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